George Magrath insider trades

Open-market stock purchases and sales by George Magrath, Chief Executive Officer at Opus Genetics, Inc, from SEC Form 4 filings since Nov 1, 2023.

Track record: 60% of 5 scored buys are up 5% or more since purchase, averaging +154%.

Recent trades

DateStockTradeValue
Sep 9, 2026IRD Opus Genetics, IncBought (not open market)$451K
Sep 9, 2026IRD Opus Genetics, IncSold (not open market)$451K
Sep 9, 2026IRD Opus Genetics, IncBought (not open market)—
Jul 23, 2026IRD Opus Genetics, IncSold$27.9K
Apr 23, 2026IRD Opus Genetics, IncSold$49.6K
Mar 16, 2026IRD Opus Genetics, IncSold$127K
Jan 22, 2026IRD Opus Genetics, IncBought (not open market)—
Nov 1, 2025IRD Opus Genetics, IncSold (not open market)$69.8K
Nov 1, 2025IRD Opus Genetics, IncSold (not open market)$69.8K

Companies traded

  • IRD Opus Genetics, Inc: 3 buys, 3 sales, last Sep 9, 2026
  • OCUP Ocuphire Pharma, Inc: 2 buys, last May 17, 2024

Get free alerts when George Magrath files a new trade →